Innovative Ovarian Cancer Biomarker Assays
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Ovarian cancer is often diagnosed at a later stage because early symptoms can be mild or non-specific. Earlier detection of ovarian cancer could improve treatment options and outcomes. Recent research has focused on the development of blood-based tests, sometimes referred to as liquid biopsy tests, which aim to look for changes in the blood that could be linked to cancer. These tests are still under investigation and are not part of routine clinical care. The purpose of this study is to evaluate several blood-based ovarian cancer tests. This will be done by comparing test results from people who have ovarian cancer with results from people who do not have cancer. The study will also collect information from standard blood tests and genetic analyses to better understand how these results relate to ovarian cancer. This study is for research purposes only. The blood-based tests being evaluated are investigational and are not used to make medical decisions or diagnoses for women taking part in the study.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Kobiety, osoby transpłciowe i niebinarne z żeńskimi narządami rodnymi, które mają raka jajnika (EOC).
- •Osoby w wieku 35 lat i starsze.
- •Osoby, u których raka jajnika zdiagnozowano na podstawie biopsji przed leczeniem lub operacją.
- •Osoby z guzem w obrębie miednicy, który może być rakiem jajnika, i które mają zaplanowaną operację lub biopsję.
- •Osoby zdrowe w wieku 35 lat i starsze, bez historii chorób nowotworowych.
- •Wszyscy uczestnicy muszą wyrazić świadomą zgodę na udział w badaniu.
✗ Disqualifies
- •Osoby, które miały wcześniej jakikolwiek rodzaj raka lub przeszły leczenie z jego powodu.
- •Osoby, którym usunięto jajnik z jakiegokolwiek powodu.
- •Osoby w ciąży lub karmiące piersią.
- •Osoby, u których stan zdrowia lub inne czynniki mogą utrudnić udział w badaniu.
Simplified criteria — AI translation
Trial details
- Minimum age
- 35 Years
- Last updated (source)
- October 1, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (7)
Vseobecna Fakultni Nemocnice V Praze
Prague, Czechia
Fakultni Nemocnice Bulovka
Prague, Czechia
National Centre for Scientific Research Demokritos
Athens, Greece
Dept of Clinical Therapeutics, Alexandra Hospital
Athens, Greece
Lithuanian University of Health Sciences
Kaunas, Lithuania
Instituto Português de Oncologia de Lisboa Francisco Gentil E.P.E.
Lisbon, Portugal
Imperial College Healthcare NHS Trust Hammersmith Hospital
London, United Kingdom
Trial contact
Michael Liontos
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 10/2/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.